InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（2 笔）
内部人交易记录
董事已披露买入
2
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Gosebruch Henry O, 董事. Insider active across 4 companies, notably AbbVie Inc.. In total, 12 reports have been recorded. Split: 2 buys · 2 sells. Total volume traded: €5.1m. History available since 7 September 2021. The latest transaction was filed on 19 August 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Gosebruch Henry O
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
6,662 股0Common StockSEC:0001659625-26-000011:0
50,000 股Common StockSEC:0001962918-25-000058:0
80,000 股0Common StockSEC:0001610717-24-000065:0
15,000 股@ US$12.6247100.0% 占其流量Common StockSEC:0001610717-23-000290:0
标准退出：2023年12月18日 (T+90)
50,000 股@ US$18.00100.0% 占其流量Common StockSEC:0001209191-23-028878:0
标准退出：2023年8月7日 (T+90)
83,960 股@ US$54.860.0012% mcap26.0% 占其流量Common Stock, $0.01 par valueSEC:0001179110-22-003108:0
15,733 股@ US$146.81050.0006% mcap12.1% 占其流量Common Stock, $0.01 par valueSEC:0001179110-22-003107:0
83,960 股@ US$54.8642.0% 占其流量Common Stock, $0.01 par valueSEC:0001179110-22-003076:0
15,733 股@ US$146.810519.6% 占其流量Common Stock, $0.01 par valueSEC:0001179110-22-001923:0
30,156 股@ US$149.5438.4% 占其流量Common Stock, $0.01 par valueSEC:0001179110-22-001841:0
36,673 股0Common Stock, $0.01 par valueSEC:0001179110-22-001513:0
30,000 股0Common Stock, $0.01 par valueSEC:0001179110-21-008720:0
12 条申报中的 12 条
About Gosebruch Henry O
Henry O Gosebruch is a director. He has 11 filings in total. In the sampled recent filings, between 2021-09-10 and 2025-05-23, buys amount to EUR 998097 and sells to EUR 4118735. The companies mentioned are AbbVie Inc., where he is EVP, Chief Strategy Officer, ACELYRIN, Inc., where he is Director, and Neumora Therapeutics, Inc., where he is President & CEO.
